In December, 2012, the World Medical Association conducted a meeting in Cape Town, South Africa to review the Declaration of Helsinki (DoH) of 2008. Representatives from South African, American, Brazilian, Danish and World Medical Associations attended the meeting. In addition, experts from Germany, Switzerland, Uruguay, Iceland, Malawi and USA gave presentations. The main topics discussed were vulnerable populations, biobanks, post study arrangements, enhancement, ethics committees and the position of international organizations.
To access the presentations visit Expert Conference on the Revision of the Declaration of Helsinki – Cape Town, 5-7 December 2012 or click for the pdf versions below:
1- Revising the Declaration of Helsinki: Challenges and limitations
2- The Eight Revision of DoH: What Should be Done?
Vulnerable Populations
6- Protecting Vulnerable Subjects
Biobanks
7- Biobanks
8- Biobanks with Particular Emphasis on Human Research Materials
Post Study Arrangements
10- Post Study Access or What Happens Once Research is Over?
11- Post Trial Access to Beneficial Products of Research- An Ethical Obligation
12- Post Trial Obligations to Host Communities
Ethics Committees
14– Revisions on Declaration of Helsinki
Enhancement
15- Research on Enhancement – An Issue for the DoH?
Positions of International Organizations
16- CIOMS Ethical Guidelines for Biomedical Research: Some Issues for the Revision
17- Strengthening Ethics Review Systems -WHO
19- European Medicines Agency Perspective
20- Revising the Declaration of Helsinki Points to Consider, TRREE – FMH
21- UNESCO and DoH
22- Selected Ethical Aspects of International Clinical Trials Federal Institute for Drugs and Medical Devices, Germany
23- Post Trial Access in Clinical Trials – Medicine Control Council, South Africa
24- International Federation of Pharmaceutical Manufacturers & Associations
Conclusions
26- Consensus building/Summing Up
27- Sentences We Did Not Hear on This Conference
No comments yet.